3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neoplasms, Unknown Primary
1
Gastrointestinal Neoplasms
1
Interventions
Carboplatin
2
Capecitabine
2
antineoplaston AS 2-1
1
antineoplaston A10
1
Topotecan
1
Paclitaxel
1
Mebendazole
1
Gemcitabine
1
Cyclophosphamide
1
Cryosurgery
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Neoplasms, Unknown Primary
×
Mebendazole
×
Clear all
NCT03628079
2020-01-22
RepoMeb
Repos Pharma
Phase 1/2
Terminated
11 enrolled